Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI

Key facts

Sponsor

S.Biomedics Co., Ltd.

Principal Investigator

Dong Ah Shin, MD

Yonsei University Health System, Severance Hospital

Intervention

Neural precursor cells derived from human embryonic stem cell line(biological)

Enrollment

5 enrolled

Eligibility

18-65 years · All sexes

Timeline

2021 – 2030

Study locations (2)

• Ajou University Hospital, Suwon, Gyeonggido, South Korea
• Yonsei University Health System, Severance Hospital, Seoul, South Korea

Collaborators

Linical Co., Ltd. · Yonsei University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Spinal cord injury

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1, PHASE2NCT06410001
  CE-STAND: Cervical Epidural STimulation After Neurologic Damage
  University of Minnesota
• RECRUITINGNANCT07204184
  Multisite Transspinal Stimulation for Augmenting Recovery in Spinal Cord Injury
  Maria Knikou, PT, MBA, PhD
• RECRUITINGNANCT06924177
  UTSW NORC Pilot Spinal Cord Injury Dietary Program
  University of Texas Southwestern Medical Center
• RECRUITINGNANCT06867809
  Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury
  Jason Carmel
• ENROLLING BY INVITATIONNANCT06873776
  Arm and Leg Cycling for Accelerated SCI Recovery
  Shirley Ryan AbilityLab
• RECRUITINGNANCT07135583
  Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
  Thomas Jefferson University
• RECRUITINGNANCT07222033
  Self-balancing Personal Exoskeleton for SCI (WINY)
  Wandercraft
• RECRUITINGPHASE1, PHASE2NCT06677229
  Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury
  Technophage, SA

See all trials for Spinal cord injury →